Alaska Wealth Advisors’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Alaska Wealth Advisors's BMY Position: Q1 2024 in Review
Alaska Wealth Advisors sold out of Bristol-Myers Squibb (BMY) in Q1 2024, closing a stake of 29,787 shares — an estimated $1.53M sold.
Alaska Wealth Advisors first reported a position in BMY in Q4 2023 and held it in 1 quarter. The position peaked at $1.53M in Q4 2023. 2,338 funds tracked by Wall St. Rank hold BMY as of Q1 2024.
- Alaska Wealth Advisors reported no remaining Bristol-Myers Squibb position as of Q1 2024 after selling out during the quarter.
- Alaska Wealth Advisors sold 29,787 Bristol-Myers Squibb shares in Q1 2024, an estimated $1.53M.
- Alaska Wealth Advisors first reported a position in Bristol-Myers Squibb in Q4 2023 and held it in 1 quarter.
- Alaska Wealth Advisors's Bristol-Myers Squibb position peaked at $1.53M in Q4 2023.
- 2,338 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2024.
Based on Alaska Wealth Advisors's 13F filing for Q1 2024, filed 18 Apr 2024.